Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2002
10/08/2002US6461848 Degrades heparin sulfate preventing deposits of beta-amyloid senile plaques
10/08/2002US6461824 Production of chimeric antibodies with specificity to human tumor antigens
10/08/2002US6461811 Gamma-herpes virus DNA and methods of use
10/08/2002US6461643 Consists of at least one biologically- active agent; (b) at least one carrier comprising an acylated aldehyde of an amino acid, an acylated ketone of an amino acid, an acylated aldehyde of a peptide, an acylated ketone of a peptide
10/08/2002US6461618 Immunizing human host against moraxella catarrhalis by administering immunogenic amount of vaccine composition comprising isolated and purified 74 kd protein of moraxella catarrhalis having specified amino acid sequence
10/08/2002US6461617 Recombinant toxin fragments
10/08/2002US6461616 EIAV p26 deletion vaccine and diagnostic
10/08/2002US6461615 Therapeutic and prophylactic methods using heat shock proteins
10/08/2002US6461605 Continuous low-dose cytokine infusion therapy
10/08/2002CA2254145C Improved process to stabilize proteins
10/08/2002CA2231046C Human protein kinases hyak3
10/08/2002CA2047119C Vitro processing of fusion proteins
10/03/2002WO2002077648A2 Pathogenic and commensal vaccine antigens
10/03/2002WO2002077267A2 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon
10/03/2002WO2002077266A2 Novel fibroblast growth factor and nucleic acids encoding same
10/03/2002WO2002077263A2 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon
10/03/2002WO2002077257A1 Novel nucleic acids and polypeptides
10/03/2002WO2002077237A2 Transporters and ion channels
10/03/2002WO2002077236A2 Compositions and methods relating to lung specific genes and proteins
10/03/2002WO2002077234A2 Compositions and methods relating to colon specific genes and proteins
10/03/2002WO2002077232A2 Compositions and methods relating to breast specific genes and proteins
10/03/2002WO2002077217A2 Human dual specificity protein phosphatase 7-like protein
10/03/2002WO2002077216A2 Ikk2 variant, dino gene, lectin-like receptor gene, and proteins encoded thereby
10/03/2002WO2002077211A2 A virus (cryptovirus) within the rubulavirus genus and uses therefor
10/03/2002WO2002077208A1 Antigen-dependent reduction of specific immune reactions by influencing the co-stimulation
10/03/2002WO2002077197A2 Methods for diagnosing and monitoring malignancies by screening gene copy numbers
10/03/2002WO2002077195A2 Plasmodium falciparum ama-1 protein and uses thereof
10/03/2002WO2002077174A2 Human cytokine receptor
10/03/2002WO2002077033A1 Antibodies against cancer
10/03/2002WO2002077029A2 Cd19-specific redirected immune cells
10/03/2002WO2002077028A1 Polypeptides and nucleic acids for bolekine
10/03/2002WO2002077027A1 Human stra6-like protein and nucleic acids encoding the same
10/03/2002WO2002077022A1 Immunogenic cell surface proteins of helicobacter pylori
10/03/2002WO2002077021A2 Streptococcus pneumoniae proteins and nucleic acids
10/03/2002WO2002077020A2 Virulence genes in h. influenzae
10/03/2002WO2002077012A2 Human papilloma virus immunoreative peptides
10/03/2002WO2002076548A2 Methods and apparatus for treating diseased tissue
10/03/2002WO2002076507A2 Uses of opg ligand to modulate immune responses
10/03/2002WO2002076504A1 Remedies for inflammatory bowel diseases
10/03/2002WO2002076503A1 Treatment of central nervous system diseases by antibodies against glatiramer acetate
10/03/2002WO2002076502A1 Human medical treatment by application of immunoglobulin a
10/03/2002WO2002076501A2 Blood cell production via activation of the hemoglobin scavenger receptor
10/03/2002WO2002076500A1 Vaccine for the treatment of tubercolosis and other intracellular infections diseases
10/03/2002WO2002076499A2 Combination treatment of pancreatic cancer
10/03/2002WO2002076498A2 Bacteriophage-mediated immunisation
10/03/2002WO2002076497A2 Method and composition
10/03/2002WO2002076494A2 USE OF CYTOKINES OF THE TGF-β SUPERFAMILY FOR THE TREATMENT AND DIAGNOSIS OF SKIN RELATED DISORDERS
10/03/2002WO2002076486A2 Histidine-rich glycoprotein
10/03/2002WO2002076485A2 Vaccine for modulating between t1 and t2 immune responses
10/03/2002WO2002076482A2 USE OF IKK-β INHIBITORS AND METHOD FOR DISCOVERY OF SAID INHIBITORS
10/03/2002WO2002076471A1 Composition comprising a prebiotic for decreasing inflammatory process and abnormal activation of non-specific immune parameters
10/03/2002WO2002076469A1 A novel technology of intracellular delivery of dna oligonucleotides to improve drug activity
10/03/2002WO2002076468A1 Tumor therapy with alphavirus-based and high affinity laminin receptor-targeted vectors
10/03/2002WO2002076437A2 Methods for treating neurodegenerative diseases including alzheimer's
10/03/2002WO2002076428A1 Liposome composition for improved intracellular delivery of a therapeutic agent
10/03/2002WO2002076391A2 Microbial feeds for aquaculture and agriculture
10/03/2002WO2002076388A2 Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting gm1-ganglioside
10/03/2002WO2002076216A1 Viral vectors and their use in therapeutic methods
10/03/2002WO2002076196A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
10/03/2002WO2002060390A3 Induction of immune responses to isoaspartyl-modified antigens
10/03/2002WO2002058728A3 Polypeptides capable of binding to cd64 and comprising one or more heterologous t cell epitopes, and their uses
10/03/2002WO2002056828A3 Helper virus-free herpes virus amplicon particles and uses thereof
10/03/2002WO2002055533A3 Methods of using imxp-888 and imxp-888 antagonists
10/03/2002WO2002034933A3 Methods and compositions for modifying biologically active target molecules
10/03/2002WO2002029086A3 Nucleic acid sequences differentially expressed in cancer tissue
10/03/2002WO2002026193A3 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
10/03/2002WO2002018595A3 Moraxella polypeptides and corresponding dna fragments and uses thereof
10/03/2002WO2002016422A3 Recombinant constructs of borrelia burgdorferi
10/03/2002WO2002009744A3 Modified sialic acid vaccines
10/03/2002WO2002002751A3 Alteration of cell membrane
10/03/2002WO2002000242A3 Human papilloma virus treatment
10/03/2002WO2001096388A3 Compositions and methods for the therapy and diagnosis of colon cancer
10/03/2002WO2001089543A3 Use of proanthocyanidins as an active ingredient of a stimulator and l-arginine or its salts as a source of nitric oxide to relieve symptoms of erectile dysfuntion
10/03/2002WO2001025254A9 Novel adjuvant comprising a lipopolysaccharide antagonist
10/03/2002WO2000073502A3 Essential genes and gene products for identifying, developing and optimising immunological and pharmacological active ingredients for the treatment of microbial infections
10/03/2002WO2000069896A9 Molecular interactions in haematopoietic cells
10/03/2002US20020144299 Nuceotide sequences coding malarial surface protein for use in the treatment and prevention of malaria
10/03/2002US20020143150 Monoclonal antibody to the clonotypic structure of a T-cell receptor, a pharmaceutical composition and a diagnostic reagent comprising the same
10/03/2002US20020143143 Peptides designed for the diagnosis and treatment of rheumatoid arthritis
10/03/2002US20020142999 Topical ophthalmic, otic or nasal drug for therapy of bacterial infections
10/03/2002US20020142987 Methods of inducing mucosal immunity
10/03/2002US20020142983 MUC-1 antagonists and methods of treating immune disorders
10/03/2002US20020142977 Administering an immunostimulatory nucleic acid molecule in an amount effective to increase antigen-specific cytotoxic T lymphocyte (CTL) activity in a CD4+ T cell-deficient individual
10/03/2002US20020142945 Immunomodulatory methods using carbohydrate antigens
10/03/2002US20020142448 Antibody for use in the diagnosis, treatment and prevention of bone disorders and cancer
10/03/2002US20020142443 Polypeptide for use in the diagnosis, treatment and prevention of cell proliferative and apoptosis disorders
10/03/2002US20020142420 Cloned leptospira outer membrane protein
10/03/2002US20020142417 Antioxidant protein 2, gene and methods of use therefor
10/03/2002US20020142414 Nucleotide sequences coding polypeptide for use in the treatment of lung defects, septic shock or inflammation
10/03/2002US20020142394 Exonuclease-mediated gene assembly in directed evolution
10/03/2002US20020142374 Generating genetically engineered antibody with expanded half-life; obtain nucleotide sequences, insert segment coding preferential immunoglobulin fragment, recover protein
10/03/2002US20020142359 Monoclonal antibody to CEA, conjugates comprising said antibody, and their therapeutic use in an adept system
10/03/2002US20020142358 Antibody for use in the diagnosis, prevention and treatment of infections, multiple sclerosis, arthritis, autoimmune, inflammation and graft versus host disease
10/03/2002US20020142357 TNF receptor action modulation
10/03/2002US20020142330 Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor
10/03/2002US20020142317 Methods for the early diagnosis of ovarian cancer
10/03/2002US20020142292 Mammalian genes; related reagents and methods
10/03/2002US20020142055 Treatment of immune system-modulated disorders
10/03/2002US20020142047 Microsphere delivery of mucin peptides
10/03/2002US20020142030 Administering by mouth freeze dried liposome absorbed with antigen; antiinflammatroy agents
1 ... 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 ... 1823